India PD-1 Non-Small Cell Lung Cancer Market (2025-2031) | Revenue, Drivers, Segmentation, Consumer Insights, Outlook, Opportunities, Supply, Restraints, Size, Competition, Strategic Insights, Trends, Demand, Growth, Forecast, Investment Trends, Segments, Industry, Challenges, Share, Value, Competitive, Analysis, Pricing Analysis, Companies, Strategy

Name: India PD-1 Non-Small Cell Lung Cancer Market (2025-2031) | Trends, Outlook & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Type (PD-1 Inhibitors, PD-L1 Inhibitors, Combination Therapy, Monotherapy, Adjuvant Therapy), By Therapy Type (Immunotherapy, Chemotherapy, Radiation Therapy, Surgery, Palliative Care), By Treatment Stage (First-Line Treatment, Second-Line Treatment, Advanced-Stage Treatment, Recurrent Cancer Treatment, Metastatic Cancer Treatment), By Mode of Action (Targeted Therapy, Checkpoint Inhibitors, Biomarker-Based Therapy, Immune Checkpoint Modulation, T-Cell Activation), By End User (Hospitals, Research Labs, Oncology Centers, Clinics, Diagnostic Centers) And Competitive Landscape

Product Code: ETC10756494	Publication Date: Apr 2025	Product Type: Market Research Report
Publisher: 6Wresearch	No. of Pages: 65	No. of Figures: 34	No. of Tables: 19

India Pd-1 Non-Small Cell Lung Cancer Market Import Shipment Trend (2020-2024)

The India PD-1 non-small cell lung cancer market import shipment demonstrated robust growth with a significant CAGR from 2020 to 2024. However, there was a slight slowdown in growth between 2023 and 2024. Overall, the market exhibited strong expansion, with a positive momentum throughout the period.

Graph Showing India pd-1 non-small cell lung cancer market Shipment Trend & Volume from 2020-2024

Key Highlights of the Report:

India PD-1 Non-Small Cell Lung Cancer Market Outlook
Market Size of India PD-1 Non-Small Cell Lung Cancer Market,2024
Forecast of India PD-1 Non-Small Cell Lung Cancer Market, 2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Revenues & Volume for the Period 2021-2031
India PD-1 Non-Small Cell Lung Cancer Market Trend Evolution
India PD-1 Non-Small Cell Lung Cancer Market Drivers and Challenges
India PD-1 Non-Small Cell Lung Cancer Price Trends
India PD-1 Non-Small Cell Lung Cancer Porter's Five Forces
India PD-1 Non-Small Cell Lung Cancer Industry Life Cycle
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Drug Type for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By PD-1 Inhibitors for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By PD-L1 Inhibitors for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Combination Therapy for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Monotherapy for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Adjuvant Therapy for the Period 2021 - 2029
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Therapy Type for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Immunotherapy for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Chemotherapy for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Radiation Therapy for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Surgery for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Palliative Care for the Period 2021 - 2029
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Treatment Stage for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By First-Line Treatment for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Second-Line Treatment for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Advanced-Stage Treatment for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Recurrent Cancer Treatment for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Metastatic Cancer Treatment for the Period 2021 - 2029
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Mode of Action for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Targeted Therapy for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Checkpoint Inhibitors for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Biomarker-Based Therapy for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Immune Checkpoint Modulation for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By T-Cell Activation for the Period 2021 - 2029
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By End User for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Hospitals for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Research Labs for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Oncology Centers for the Period 2021-2031
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Clinics for the Period 2021 - 2029
Historical Data and Forecast of India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume By Diagnostic Centers for the Period 2021 - 2029
India PD-1 Non-Small Cell Lung Cancer Import Export Trade Statistics
Market Opportunity Assessment By Drug Type
Market Opportunity Assessment By Therapy Type
Market Opportunity Assessment By Treatment Stage
Market Opportunity Assessment By Mode of Action
Market Opportunity Assessment By End User
India PD-1 Non-Small Cell Lung Cancer Top Companies Market Share
India PD-1 Non-Small Cell Lung Cancer Competitive Benchmarking By Technical and Operational Parameters
India PD-1 Non-Small Cell Lung Cancer Company Profiles
India PD-1 Non-Small Cell Lung Cancer Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India PD-1 Non-Small Cell Lung Cancer Market Overview

3.1 India Country Macro Economic Indicators

3.2 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, 2021 & 2031F

3.3 India PD-1 Non-Small Cell Lung Cancer Market - Industry Life Cycle

3.4 India PD-1 Non-Small Cell Lung Cancer Market - Porter's Five Forces

3.5 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.7 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Treatment Stage, 2021 & 2031F

3.8 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Mode of Action, 2021 & 2031F

3.9 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F

4 India PD-1 Non-Small Cell Lung Cancer Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-small cell lung cancer in India

4.2.2 Growing awareness about the benefits of PD-1 inhibitors in treating non-small cell lung cancer

4.2.3 Rising healthcare expenditure and improving access to advanced cancer treatments in India

4.3 Market Restraints

4.3.1 High cost associated with PD-1 inhibitors limiting affordability for many patients

4.3.2 Regulatory challenges and approval processes for new cancer treatments in India

5 India PD-1 Non-Small Cell Lung Cancer Market Trends

6 India PD-1 Non-Small Cell Lung Cancer Market, By Types

6.1 India PD-1 Non-Small Cell Lung Cancer Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Drug Type, 2021 - 2031F

6.1.3 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By PD-1 Inhibitors, 2021 - 2031F

6.1.4 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By PD-L1 Inhibitors, 2021 - 2031F

6.1.5 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Combination Therapy, 2021 - 2031F

6.1.6 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Monotherapy, 2021 - 2031F

6.1.7 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Adjuvant Therapy, 2021 - 2031F

6.2 India PD-1 Non-Small Cell Lung Cancer Market, By Therapy Type

6.2.1 Overview and Analysis

6.2.2 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F

6.2.3 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F

6.2.4 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F

6.2.5 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Surgery, 2021 - 2031F

6.2.6 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Palliative Care, 2021 - 2031F

6.3 India PD-1 Non-Small Cell Lung Cancer Market, By Treatment Stage

6.3.1 Overview and Analysis

6.3.2 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By First-Line Treatment, 2021 - 2031F

6.3.3 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Second-Line Treatment, 2021 - 2031F

6.3.4 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Advanced-Stage Treatment, 2021 - 2031F

6.3.5 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Recurrent Cancer Treatment, 2021 - 2031F

6.3.6 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Metastatic Cancer Treatment, 2021 - 2031F

6.4 India PD-1 Non-Small Cell Lung Cancer Market, By Mode of Action

6.4.1 Overview and Analysis

6.4.2 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F

6.4.3 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F

6.4.4 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Biomarker-Based Therapy, 2021 - 2031F

6.4.5 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Immune Checkpoint Modulation, 2021 - 2031F

6.4.6 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By T-Cell Activation, 2021 - 2031F

6.5 India PD-1 Non-Small Cell Lung Cancer Market, By End User

6.5.1 Overview and Analysis

6.5.2 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Hospitals, 2021 - 2031F

6.5.3 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Research Labs, 2021 - 2031F

6.5.4 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Oncology Centers, 2021 - 2031F

6.5.5 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Clinics, 2021 - 2031F

6.5.6 India PD-1 Non-Small Cell Lung Cancer Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F

7 India PD-1 Non-Small Cell Lung Cancer Market Import-Export Trade Statistics

7.1 India PD-1 Non-Small Cell Lung Cancer Market Export to Major Countries

7.2 India PD-1 Non-Small Cell Lung Cancer Market Imports from Major Countries

8 India PD-1 Non-Small Cell Lung Cancer Market Key Performance Indicators

8.1 Patient survival rates post PD-1 inhibitor treatment

8.2 Number of clinical trials and studies on PD-1 inhibitors in India

8.3 Adoption rate of PD-1 inhibitors in the treatment protocol for non-small cell lung cancer in India

9 India PD-1 Non-Small Cell Lung Cancer Market - Opportunity Assessment

9.1 India PD-1 Non-Small Cell Lung Cancer Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 India PD-1 Non-Small Cell Lung Cancer Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.3 India PD-1 Non-Small Cell Lung Cancer Market Opportunity Assessment, By Treatment Stage, 2021 & 2031F

9.4 India PD-1 Non-Small Cell Lung Cancer Market Opportunity Assessment, By Mode of Action, 2021 & 2031F

9.5 India PD-1 Non-Small Cell Lung Cancer Market Opportunity Assessment, By End User, 2021 & 2031F

10 India PD-1 Non-Small Cell Lung Cancer Market - Competitive Landscape

10.1 India PD-1 Non-Small Cell Lung Cancer Market Revenue Share, By Companies, 2024

10.2 India PD-1 Non-Small Cell Lung Cancer Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa PD-1 Non-Small Cell Lung Cancer Market

Cuba PD-1 Non-Small Cell Lung Cancer Market

Cyprus PD-1 Non-Small Cell Lung Cancer Market

Denmark PD-1 Non-Small Cell Lung Cancer Market

Djibouti PD-1 Non-Small Cell Lung Cancer Market

Dominica PD-1 Non-Small Cell Lung Cancer Market

Europe PD-1 Non-Small Cell Lung Cancer Market

Global PD-1 Non-Small Cell Lung Cancer Market

Middle East PD-1 Non-Small Cell Lung Cancer Market

North America PD-1 Non-Small Cell Lung Cancer Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here